Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.

Julio Rosenstock Harpreet S Bajaj Andrej Janez Robert SilverKamilla BegtrupMelissa Voigt Hansen Ting Jia Ronald M Goldenbergnull null

Published in: The New England journal of medicine (2020)

Once-weekly treatment with insulin icodec had glucose-lowering efficacy and a safety profile similar to those of once-daily insulin glargine U100 in patients with type 2 diabetes. (Funded by Novo Nordisk; NN1436-4383 ClinicalTrials.gov number, NCT03751657.).

Keyphrases

type diabetes
glycemic control
blood glucose
blood pressure
weight loss
adipose tissue
combination therapy